KRAS and cancer: Recent comprehensive analyses have shown that pathological mutations in cancer-related genes such as KRAS and PIK3CA are frequently observed in endometriosis [107,108], and these oncogenic abnormalities may lead to high expression of TF and IL6 in endometriosis.